- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 980658, 11 pages
Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy
1Department of Physiology, University of Siena, Via Aldo Moro, 7-53100 Siena, Italy
2Department of Biology and Evolution, University of Ferrara, Via Luigi Borsari 46, 44100 Ferrara, Italy
3Department of Food and Nutrition, Kyung Hee University, Seoul 130-701, Republic of Korea
4Department of Cytokinetics, Institute of Biophysics AS CR, v.v.i. Kralovopolska 135, 612 65 Brno, Czech Republic
5Center of Biomolecular and Cellular Engineering and International Clinical Research Center, St. Anne’s University Hospital Brno, 1656 91 Brno, Czech Republic
6Department of Biomedical Sciences, University of Siena, Via Aldo Moro, 7-53100 Siena, Italy
Received 22 October 2012; Revised 26 November 2012; Accepted 28 November 2012
Academic Editor: Chun-Tao Che
Copyright © 2012 Claudia Torricelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. Moretti, E. S. Yang, K. W. Kim, and B. Lu, “Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy,” Drug Resistance Updates, vol. 10, no. 4-5, pp. 135–143, 2007.
- V. R. Patel, M. G. Patel, and R. K. Patel, “Development and validation of a RP-HPLC method for quantification of rottlerin in Kamala (Mallotus philppinensis),” Drug Invention Today, vol. 1, no. 2, pp. 116–118, 2009.
- C. Torricelli, V. Fortino, E. Capurro et al., “Rottlerin inhibits the nuclear factor κB/Cyclin-D1 cascade in MCF-7 breast cancer cells,” Life Sciences, vol. 82, no. 11-12, pp. 638–643, 2008.
- E. Maioli, L. Greci, K. Soucek et al., “Rottlerin inhibits ROS formation and prevents NFB activation in MCF-7 and HT-29 cells,” Journal of Biomedicine and Biotechnology, vol. 2009, Article ID 742936, 7 pages, 2009.
- G. Valacchi, A. Pecorelli, M. Mencarelli et al., “Rottlerin: a multifaced regulator of keratinocyte cell cycle,” Experimental Dermatology, vol. 18, no. 6, pp. 516–521, 2009.
- G. Valacchi, A. Pecorelli, C. Sticozzi et al., “Rottlerin exhibits antiangiogenic effects in vitro,” Chemical Biology and Drug Design, vol. 77, no. 6, pp. 460–470, 2011.
- J. Zhang, N. Liu, J. Zhang, S. Liu, Y. Liu, and D. Zheng, “PKCδ protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis,” Journal of Cellular Biochemistry, vol. 96, no. 3, pp. 522–532, 2005.
- D. M. Tillman, K. Izeradjene, K. S. Szucs, L. Douglas, and J. A. Houghton, “Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C,” Cancer Research, vol. 63, no. 16, pp. 5118–5125, 2003.
- J. H. Lim, J. W. Park, K. S. Choi, Y. B. Park, and T. K. Kwon, “Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC δ-independent mechanism in human malignant tumor cells,” Carcinogenesis, vol. 30, no. 5, pp. 729–736, 2009.
- U. Akar, B. Ozpolat, K. Mehta, J. Fok, Y. Kondo, and G. Lopez-Berestein, “Tissue transglutaminase inhibits autophagy in pancreatic cancer cells,” Molecular Cancer Research, vol. 5, no. 3, pp. 241–249, 2007.
- A. D. Balgi, B. D. Fonseca, E. Donohue et al., “Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling,” PLoS ONE, vol. 4, no. 9, Article ID e7124, 2009.
- K. S. Song, J. S. Kim, E. J. Yun et al., “Rottlerin induces autophagy and apoptotic cell death through a PKC-δ-independent pathway in HT1080 human fibrosarcoma cells: the protective role of autophagy in apoptosis,” Autophagy, vol. 4, no. 5, pp. 650–658, 2008.
- E. Maioli, C. Torricelli, and G. Valacchi, “Rottlerin and cancer: novel evidence and mechanisms,” The Scientific World Journal, vol. 2012, Article ID 350826, 11 pages, 2012.
- E. Maioli, C. Torricelli, and G. Valacchi, “Rottlerin and curcumin: a comparative analysis,” Annals of the New York Academy of Sciences, vol. 1259, pp. 65–76, 2012.
- M. Gschwendt, H. J. Miller, and K. Kielbassa, “Rottlerin, a novel protein kinase inhibitor,” Biochemical and Biophysical Research Communication, vol. 199, no. 1, pp. 93–98, 1994.
- S. P. Davies, H. Reddy, M. Caivano, and P. Cohen, “Specificity and mechanism of action of some commonly used protein kinase inhibitors,” Biochemical Journal, vol. 351, part 1, pp. 95–105, 2000.
- S. I. Zakharov, J. P. Morrow, G. Liu, L. Yang, and S. O. Marx, “Activation of the BK (SLO1) potassium channel by mallotoxin,” The Journal of Biological Chemistry, vol. 280, no. 35, pp. 30882–30887, 2005.
- S. P. Soltoff, “Rottlerin: an inappropriate and ineffective inhibitor of PKCδ,” Trends in Pharmacological Sciences, vol. 28, no. 9, pp. 453–458, 2007.
- R. U. Jänicke, “MCF-7 breast carcinoma cells do not express caspase-3,” Breast Cancer Research and Treatment, vol. 117, no. 1, pp. 219–221, 2009.
- U. Akar, A. Chaves-Reyez, M. Barria et al., “Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells,” Autophagy, vol. 4, no. 5, pp. 669–679, 2008.
- A. Kihara, Y. Kabeya, Y. Ohsumi, and T. Yoshimori, “Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network,” EMBO Reports, vol. 2, no. 4, pp. 330–335, 2001.
- X. H. Liang, S. Jackson, M. Seaman et al., “Induction of autophagy and inhibition of tumorigenesis by beclin 1,” Nature, vol. 402, no. 6762, pp. 672–676, 1999.
- A. Kumar, J. Xu, S. Brady et al., “Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells,” PLoS ONE, vol. 5, no. 10, Article ID e13390, 2010.
- F. Essmann, I. H. Engels, G. Totzke, K. Schulze-Osthoff, and R. U. Jänicke, “Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event,” Cancer Research, vol. 64, no. 19, pp. 7065–7072, 2004.
- P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990.
- A. Biederbick, H. F. Kern, and H. P. Elsasser, “Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles,” European Journal of Cell Biology, vol. 66, no. 1, pp. 3–14, 1995.
- K. Yamamoto, H. Ichijo, and S. J. Korsmeyer, “BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M,” Molecular and Cellular Biology, vol. 19, no. 12, pp. 8469–8478, 1999.
- E. Maioli, C. Torricelli, V. Fortino, F. Carlucci, V. Tommassini, and A. Pacini, “Critical appraisal of the MTT assay in the presence of Rottlerin and uncouplers,” Biological Procedures Online, vol. 11, no. 1, pp. 227–240, 2009.
- Y. Kabeya, N. Mizushima, T. Ueno et al., “LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing,” The EMBO Journal, vol. 19, no. 21, pp. 5720–5728, 2000.
- A. Petiot, E. Ogier-Denis, E. F. C. Blommaart, A. J. Meijer, and P. Codogno, “Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pa7thways that control macroautophagy in HT-29 cells,” The Journal of Biological Chemistry, vol. 275, no. 2, pp. 992–998, 2000.
- J. L. Luo, H. Kamata, and M. Karin, “IKK/NF-κB signaling: balancing life and death—a new approach to cancer therapy,” The Journal of Clinical Investigation, vol. 115, no. 10, pp. 2625–2632, 2005.
- T. Banno, A. Gazel, and M. Blumenberg, “Pathway-specific profiling identifies the NF-κB-dependent tumor necrosis factor α-regulated genes in epidermal keratinocytes,” The Journal of Biological Chemistry, vol. 280, no. 19, pp. 18973–18980, 2005.
- M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006.
- J. G. Walsh, S. P. Cullen, C. Sheridan, A. U. Lüthi, C. Gerner, and S. J. Martin, “Executioner caspase-3 and caspase-7 are functionally distinct proteases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 12815–12819, 2008.
- S. Pattingre, A. Tassa, X. Qu et al., “Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy,” Cell, vol. 122, no. 6, pp. 927–939, 2005.
- B. N. Singh, D. Kumar, S. Shankar, and R. K. Srivastava, “Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells,” Biochemical Pharmacology, vol. 84, no. 9, pp. 1154–1163, 2012.
- B. Fazi, W. Bursch, G. M. Fimia et al., “Fenretinide induces autophagic cell death in caspase-defective breast cancer cells,” Autophagy, vol. 4, no. 4, pp. 435–441, 2008.
- F. Scarlatti, R. Maffei, I. Beau, P. Codogno, and R. Ghidoni, “Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells,” Cell Death and Differentiation, vol. 15, no. 8, pp. 1318–1329, 2008.